Philips to distribute Corindus robotic-assisted PCI system

| | Health Exec | Artificial Intelligence
Robotics - 164.83 Kb
Corindus Vascular Robotics receives FDA 510(k) clearance for the CorPath 200 System to assist interventional cardiologists in performing PCI. Source: Corindus Vascular Robotics
Royal Philips Electronics and Corindus Vascular Robotics have signed a U.S. distribution agreement for Corindus’ CorPath 200 system, the recently FDA-approved robotic-assisted system to be used during PCI procedures.

The financial details of the exclusive distribution agreement were not disclosed. Philips owns a minority share in the Natick, Mass.-based Corindus, which commercializes robotic-assisted systems for interventional cardiology procedures.

The CorPath 200 system can be integrated with x-ray fluoroscopy systems including Philips’ Allura x-ray equipment. The robotic-assisted system can be used with standard stents, catheters and guidewires, the companies said in a press release. The CorPath 200 system is operated by the interventional cardiologist from a radiation shielded, interventional cockpit.

The distribution agreement enables both companies to sell the robotic-assisted system in the U.S.

Related Content

AdvaMed itemizes AI imperatives for ‘the entire healthcare ecosystem’
6 things high-achieving orgs do to wring real value from AI
A modest proposal to rally AI regulators around a simple game plan
4 points crucial to the nimble regulation of GenAI
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT
FDA clears AI tool that flags signs of heart disease in chest CT scans

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Design by Adaptive Theme
Trimed Popup
Trimed Popup